Abstract
This commentary, based on the paper by Buijs et al. [1] in the current issue of CMI, discusses the importance of monitoring serological titre changes in patients with chronic Q fever. The authors evaluated phase I IgG dynamics and the association with Q fever complications and therapy failure. Contrary to common perceptions, they found no association between antibody dynamics during the patient follow-up period and various clinical outcomes. These findings challenge current practice, which puts considerable value on serological changes while monitoring the patient's response to therapy in chronic Q fever.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
